US medical devices industry saw a drop of 6.52% in overall deal activity during August 2021, when compared with the last 12-month average, led by 22C Capital, Insight Partners and Nordic Capital’s $7.3bn private equity deal with Inovalon Holdings, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
A total of 86 deals worth $12.9bn were announced in August 2021, compared with the 12-month average of 92 deals.
venture financing was the leading category in the month in terms of volume with 59 deals, which accounted for 68.6% of all deals.
In second place was M&A with 18 deals, followed by private equity with nine transactions, respectively accounting for 20.9% and 10.5% of overall deal activity in the US technology industry during the month.
In terms of value of deals, private equity was the leading deal category in the US medical devices industry with total deals worth $7.59bn, while M&A and venture financing deals totalled $4.11bn and $1.24bn respectively.
US medical devices industry deals in August 2021: Top deals
The top five medical devices industry deals accounted for 88.6% of the overall value during August 2021.
The combined value of the top five medical devices deals stood at $11.46bn, against the overall value of $12.9bn recorded for the month.
The top five medical devices industry deals of August 2021 tracked by GlobalData were:
1) 22C Capital,Insight Partners and Nordic Capital $7.3bn private equity deal with Inovalon Holdings
2) The $2.5bn acquisition of Smiths Medical by Trulli Bidco
3) Medtronic $1.1bn acquisition deal with Intersect ENT
4) The $340m acquisition of BioVision by Abcam
5) Adams Street Partners,Battery Ventures,Coatue Management,ICONIQ Growth and Sierra Ventures $220m venture financing deal with Reify Health